Last reviewed · How we verify

NCT06820801: PFM

Assessment of PFM Strength and Function After Radiotherapy Treatment in Women With Pelvic Cancers

Completed Last updated 26 February 2025
What this trial tests

trial testing pelvic floor muscles strength and function in Pelvic Muscle Strength and Function in 60 participants. Completed in 10 December 2024.

Timeline
10 January 2024
Primary endpoint
10 December 2024
10 December 2024

Quick facts

Lead sponsorCairo University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment60
Start date10 January 2024
Primary completion10 December 2024
Estimated completion10 December 2024
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 30 to 50, female only, with Pelvic Muscle Strength and Function. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Assessment the effect of radiotherapy treatment on pelvic floor muscles in women with pelvic cancers

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06820801.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing